Furthermore, the regulatory effect of VCAM-1 activation and cross-linking on multiple signalling pathways—including vascular permeability [33], angiogenesis [42, 74], and anti-apoptosis [62]—also explains the broad involvement of the protein in both IBD and CRC despite the pathophysiological differences between the two diseases. This evidence concerns the gene VCAM1 and inflammatory bowel disease.